1. Home
  2. MOGU vs MRKR Comparison

MOGU vs MRKR Comparison

Compare MOGU & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MOGU Inc.

MOGU

MOGU Inc.

HOLD

Current Price

$2.17

Market Cap

22.5M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.37

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGU
MRKR
Founded
2011
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5M
24.5M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
MOGU
MRKR
Price
$2.17
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.25
AVG Volume (30 Days)
8.1K
157.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$0.81
52 Week High
$8.10
$4.07

Technical Indicators

Market Signals
Indicator
MOGU
MRKR
Relative Strength Index (RSI) 41.42 41.01
Support Level $2.02 $0.83
Resistance Level $2.26 $1.44
Average True Range (ATR) 0.20 0.11
MACD -0.05 -0.01
Stochastic Oscillator 10.67 13.92

Price Performance

Historical Comparison
MOGU
MRKR

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: